{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T08:04:26Z","timestamp":1782979466445,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,26]]},"DOI":"10.7759\/cureus.79722","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T04:59:40Z","timestamp":1740632380000},"source":"Crossref","is-referenced-by-count":1,"title":["Drug Usability Survey (DUS) of Gabapentinoid and Its Combinations Among Indian Patients With Neuropathic Pain: Results From a Real-World, Multicenter, Retrospective Survey at Neurology Clinics"],"prefix":"10.7759","author":[{"given":"Puneet","family":"Aggarwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pashupati Nath","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VN","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran C","family":"Velivela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siraj","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesha","family":"Khalse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.13075\/ijomeh.1896.01676","article-title":"Neuropathic pain and chronic pain as an underestimated interdisciplinary problem","volume":"35","author":"Szewczyk AK","year":"2022","unstructured":"Szewczyk AK, Jamroz-Wi\u015bniewska A, Haratym N, Rejdak K. Neuropathic pain and chronic pain as an underestimated interdisciplinary problem. Int J Occup Med Environ Health. 2022, 35:249-64. 10.13075\/ijomeh.1896.01676","journal-title":"Int J Occup Med Environ Health"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.2","article-title":"Neuropathic pain","volume":"3","author":"Colloca L","year":"2017","unstructured":"Colloca L, Ludman T, Bouhassira D, et al.. Neuropathic pain. Nat Rev Dis Primers. 2017, 3:17002. 10.1038\/nrdp.2017.2","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2015.05.004","article-title":"Peripheral neuropathy: a practical approach to diagnosis and symptom management","volume":"90","author":"Watson JC","year":"2015","unstructured":"Watson JC, Dyck PJ. Peripheral neuropathy: a practical approach to diagnosis and symptom management. Mayo Clin Proc. 2015, 90:940-51. 10.1016\/j.mayocp.2015.05.004","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci12121727","article-title":"Review of the treatments for central neuropathic pain","volume":"12","author":"Sheldon BL","year":"2022","unstructured":"Sheldon BL, Olmsted ZT, Sabourin S, Heydari E, Harland TA, Pilitsis JG. Review of the treatments for central neuropathic pain. Brain Sci. 2022, 12:1727. 10.3390\/brainsci12121727","journal-title":"Brain Sci"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2019.00087","article-title":"Peripheral demyelinating diseases: from biology to translational medicine","volume":"10","author":"Kamil K","year":"2019","unstructured":"Kamil K, Yazid MD, Idrus RB, Das S, Kumar J. Peripheral demyelinating diseases: from biology to translational medicine. Front Neurol. 2019, 10:87. 10.3389\/fneur.2019.00087","journal-title":"Front Neurol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-017-0091-4","article-title":"Pharmacotherapy for neuropathic pain: a review","volume":"6","author":"Fornasari D","year":"2017","unstructured":"Fornasari D. Pharmacotherapy for neuropathic pain: a review. Pain Ther. 2017, 6:25-33. 10.1007\/s40122-017-0091-4","journal-title":"Pain Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/2058738419838383","article-title":"The neuropathic pain: an overview of the current treatment and future therapeutic approaches","volume":"33","author":"Cavalli E","year":"2019","unstructured":"Cavalli E, Mammana S, Nicoletti F, Bramanti P, Mazzon E. The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol. 2019, 33:2058738419838383. 10.1177\/2058738419838383","journal-title":"Int J Immunopathol Pharmacol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks CW","year":"2019","unstructured":"Hicks CW, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep. 2019, 19:86. 10.1007\/s11892-019-1212-8","journal-title":"Curr Diab Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/2091960","article-title":"Quality of life in painful peripheral neuropathies: a systematic review","volume":"2019","author":"Girach A","year":"2019","unstructured":"Girach A, Julian TH, Varrassi G, Paladini A, Vadalouka A, Zis P. Quality of life in painful peripheral neuropathies: a systematic review. Pain Res Manag. 2019, 2019:2091960. 10.1155\/2019\/2091960","journal-title":"Pain Res Manag"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2018.08.005","article-title":"Pharmacological treatments of neuropathic pain: the latest recommendations","volume":"175","author":"Attal N","year":"2019","unstructured":"Attal N. Pharmacological treatments of neuropathic pain: the latest recommendations. Rev Neurol (Paris). 2019, 175:46-50. 10.1016\/j.neurol.2018.08.005","journal-title":"Rev Neurol (Paris)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/pm\/pnz075","article-title":"A comprehensive algorithm for management of neuropathic pain","volume":"20","author":"Bates D","year":"2019","unstructured":"Bates D, Schultheis BC, Hanes MC, et al.. A comprehensive algorithm for management of neuropathic pain. Pain Med. 2019, 20:S2-S12. 10.1093\/pm\/pnz075","journal-title":"Pain Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2023.108546","article-title":"Neuropathic pain: from actual pharmacological treatments to new therapeutic horizons","volume":"251","author":"Thouaye M","year":"2023","unstructured":"Thouaye M, Yalcin I. Neuropathic pain: from actual pharmacological treatments to new therapeutic horizons. Pharmacol Ther. 2023, 251:108546. 10.1016\/j.pharmthera.2023.108546","journal-title":"Pharmacol Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/ijpn.ijpn_47_18","article-title":"Pharmacological management of neuropathic pain in India: a consensus statement from Indian experts","volume":"32","author":"Saxena AK","year":"2018","unstructured":"Saxena AK, Jain P, Dureja GP, et al.. Pharmacological management of neuropathic pain in India: a consensus statement from Indian experts. Indian J Pain. 2018, 32:132-44. 10.4103\/ijpn.ijpn_47_18","journal-title":"Indian J Pain"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.010","article-title":"Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)","volume":"114","author":"Bouhassira D","year":"2005","unstructured":"Bouhassira D, Attal N, Alchaar H, et al.. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005, 114:29-36. 10.1016\/j.pain.2004.12.010","journal-title":"Pain"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9091239","article-title":"A review of the clinical and therapeutic implications of neuropathic pain","volume":"9","author":"Balzani E","year":"2021","unstructured":"Balzani E, Fanelli A, Malafoglia V, et al.. A review of the clinical and therapeutic implications of neuropathic pain. Biomedicines. 2021, 9:1239. 10.3390\/biomedicines9091239","journal-title":"Biomedicines"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1108","article-title":"Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K","volume":"34","author":"Abbott CA","year":"2011","unstructured":"Abbott CA, Malik RA, van Ross ER, Kulkarni J, Boulton AJ. Prevalence and characteristics of painful diabetic neuropathy in a large community-based diabetic population in the U.K. Diabetes Care. 2011, 34:2220-4. 10.2337\/dc11-1108","journal-title":"Diabetes Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.060146","article-title":"Neuropathic pain: a practical guide for the clinician","volume":"175","author":"Gilron I","year":"2006","unstructured":"Gilron I, Watson CP, Cahill CM, Moulin DE. Neuropathic pain: a practical guide for the clinician. CMAJ. 2006, 175:265-75. 10.1503\/cmaj.060146","journal-title":"CMAJ"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3410\/M1-76","article-title":"Diagnosis and assessment of neuropathic pain","volume":"1","author":"May S","year":"2009","unstructured":"May S, Serpell M. Diagnosis and assessment of neuropathic pain. F1000 Med Rep. 2009, 1:10.3410\/M1-76","journal-title":"F1000 Med Rep"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3344\/kjp.2017.30.3.183","article-title":"Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?","volume":"30","author":"Kamble SV","year":"2017","unstructured":"Kamble SV, Motlekar SA, D'souza LL, Kudrigikar VN, Rao SE. Low doses of amitriptyline, pregabalin, and gabapentin are preferred for management of neuropathic pain in India: is there a need for revisiting dosing recommendations?. Korean J Pain. 2017, 30:183-91. 10.3344\/kjp.2017.30.3.183","journal-title":"Korean J Pain"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain - United States, 2016","volume":"65","author":"Dowell D","year":"2016","unstructured":"Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain - United States, 2016. MMWR Recomm Rep. 2016, 65:1-49. 10.15585\/mmwr.rr6501e1","journal-title":"MMWR Recomm Rep"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.205","article-title":"Mechanisms of the gabapentinoids and \u03b1 2 \u03b4-1 calcium channel subunit in neuropathic pain","volume":"4","author":"Patel R","year":"2016","unstructured":"Patel R, Dickenson AH. Mechanisms of the gabapentinoids and \u03b1 2 \u03b4-1 calcium channel subunit in neuropathic pain. Pharmacol Res Perspect. 2016, 4:e00205. 10.1002\/prp2.205","journal-title":"Pharmacol Res Perspect"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/01.BRS.0000048464.57011.00","article-title":"Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms","volume":"28","author":"Ahn SH","year":"2003","unstructured":"Ahn SH, Park HW, Lee BS, Moon HW, Jang SH, Sakong J, Bae JH. Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms. Spine (Phila Pa 1976). 2003, 28:341-6; discussion 346-7. 10.1097\/01.BRS.0000048464.57011.00","journal-title":"Spine (Phila Pa 1976)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore RA","year":"2011","unstructured":"Moore RA, Wiffen PJ, Derry S, McQuay HJ. Gabapentin for chronic neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2011, CD007938. 10.1002\/14651858.CD007938.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-015-0150-5","article-title":"Clinical practice guidelines for the management of neuropathic pain: a systematic review","volume":"16","author":"Deng Y","year":"2016","unstructured":"Deng Y, Luo L, Hu Y, Fang K, Liu J. Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC Anesthesiol. 2016, 16:12. 10.1186\/s12871-015-0150-5","journal-title":"BMC Anesthesiol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40122-020-00189-x","article-title":"Gabapentinoid benefit and risk stratification: mechanisms over myth","volume":"9","author":"McAnally H","year":"2020","unstructured":"McAnally H, Bonnet U, Kaye AD. Gabapentinoid benefit and risk stratification: mechanisms over myth. Pain Ther. 2020, 9:441-52. 10.1007\/s40122-020-00189-x","journal-title":"Pain Ther"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.2174\/0929867329666220407093727","article-title":"Review of voltage-gated calcium channel \u03b12\u03b4 subunit ligands for the treatment of chronic neuropathic pain and insight into structure-activity relationship (SAR) by pharmacophore modeling","volume":"29","author":"Chen Y","year":"2022","unstructured":"Chen Y, Wu Q, Jin Z, Qin Y, Meng F, Zhao G. Review of voltage-gated calcium channel \u03b12\u03b4 subunit ligands for the treatment of chronic neuropathic pain and insight into structure-activity relationship (SAR) by pharmacophore modeling. Curr Med Chem. 2022, 29:5097-112. 10.2174\/0929867329666220407093727","journal-title":"Curr Med Chem"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.02.021","article-title":"The \u03b12\u03b4-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions","volume":"22","author":"Chen J","year":"2018","unstructured":"Chen J, Li L, Chen SR, et al.. The \u03b12\u03b4-1-NMDA receptor complex is critically involved in neuropathic pain development and gabapentin therapeutic actions. Cell Rep. 2018, 22:2307-21. 10.1016\/j.celrep.2018.02.021","journal-title":"Cell Rep"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/biom13121802","article-title":"Combination drug therapy for the management of chronic neuropathic pain","volume":"13","author":"Boccella S","year":"2023","unstructured":"Boccella S, De Filippis L, Giorgio C, et al.. Combination drug therapy for the management of chronic neuropathic pain. Biomolecules. 2023, 13:1802. 10.3390\/biom13121802","journal-title":"Biomolecules"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2024.104232","article-title":"Neuropathic pain: Evidence based recommendations","volume":"53","author":"Moisset X","year":"2024","unstructured":"Moisset X. Neuropathic pain: Evidence based recommendations. Presse Med. 2024, 53:104232. 10.1016\/j.lpm.2024.104232","journal-title":"Presse Med"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-023-01318-y","article-title":"Monotherapy versus combination therapy in the treatment of painful diabetic neuropathy: a systematic review and meta-analysis","volume":"43","author":"Medeiros Dantas J","year":"2023","unstructured":"Medeiros Dantas J, de Jesus Oliveira M, Silva LA, Batista S, Dagostin CS, Schachter DC. Monotherapy versus combination therapy in the treatment of painful diabetic neuropathy: a systematic review and meta-analysis. Clin Drug Investig. 2023, 43:905-14. 10.1007\/s40261-023-01318-y","journal-title":"Clin Drug Investig"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1177\/2049463720912496","article-title":"Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice","volume":"14","author":"Chincholkar M","year":"2020","unstructured":"Chincholkar M. Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain. 2020, 14:104-14. 10.1177\/2049463720912496","journal-title":"Br J Pain"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup NB","year":"2015","unstructured":"Finnerup NB, Attal N, Haroutounian S, et al.. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015, 14:162-73. 10.1016\/S1474-4422(14)70251-0","journal-title":"Lancet Neurol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-022-01528-y","article-title":"The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials","volume":"45","author":"Meaadi J","year":"2023","unstructured":"Meaadi J, Obara I, Eldabe S, Nazar H. The safety and efficacy of gabapentinoids in the management of neuropathic pain: a systematic review with meta-analysis of randomised controlled trials. Int J Clin Pharm. 2023, 45:556-65. 10.1007\/s11096-022-01528-y","journal-title":"Int J Clin Pharm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/331073-drug-usability-survey-dus-of-gabapentinoid-and-its-combinations-among-indian-patients-with-neuropathic-pain-results-from-a-real-world-multicenter-retrospective-survey-at-neurology-clinics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T04:59:43Z","timestamp":1740632383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/331073-drug-usability-survey-dus-of-gabapentinoid-and-its-combinations-among-indian-patients-with-neuropathic-pain-results-from-a-real-world-multicenter-retrospective-survey-at-neurology-clinics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,26]]},"references-count":33,"URL":"https:\/\/doi.org\/10.7759\/cureus.79722","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,26]]}}}